NCT00994370View on ClinicalTrials.gov

Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Liver Cancer
Trial Locations (1)

08901

Robert Wood Johnson University Hospital, New Brunswick

Sponsors

Collaborators (1)

Sirtex Medical
All Listed Sponsors
collaborator

Sirtex Medical

INDUSTRY

lead

Rutgers, The State University of New Jersey

OTHER